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In Brief Graham et al. functionally dissect a complex genetic locus associated with inflammatory bowel disease. They find that TMEM258 is required for efficient N-linked protein glycosylation and, as such, is a central mediator of ER homeostasis in the context of intestinal inflammation.
INTRODUCTION
Mucosal homeostasis maintains a delicate balance between host defense against pathogens and tolerance to commensal microorganisms. In the case of inflammatory bowel disease (IBD), this balance is disturbed as a result of genetic and environmental factors that collectively trigger an unrestrained inflammatory response to commensals (Graham and Xavier, 2013; Khor et al., 2011) . While the etiology of IBD is incompletely understood, significant insights into its pathophysiology have been ascertained from genomewide association studies (GWASs). To date, GWASs have implicated more than 200 loci in IBD (Jostins et al., 2012; Liu et al., 2015) , yet many of these loci contain multiple genes that are in linkage disequilibrium (LD), and conclusive identification of the IBD risk gene in most loci has been challenging. In a few notable examples, causal variants associated with IBD risk have been identified by GWAS (e.g., NOD2 and ATG16L1) (Huang, 2015) . In the vast majority of IBD loci, more targeted approaches are necessary to establish causality. Successful approaches include fine mapping by dense genotyping (Jostins et al., 2012) , deep exome sequencing to identify rare coding variants (Beaudoin et al., 2013; Rivas et al., 2011) , and integrative functional approaches combining genotyping and metadata such as epigenetics and expression quantitative trait loci (eQTL) (Farh et al., 2015; Okada et al., 2014) .
Despite successful approaches to fine mapping causal variants, several complex loci associated with IBD remain unresolved. One such locus on human chromosome 11 (61.5-61.65 Mb) has been associated with IBD and also phenotypes related to lipid metabolism, coronary artery disease (CAD), and rheumatoid arthritis (RA) (Ameur et al., 2012; Hester et al., 2014; Jostins et al., 2012; Liu et al., 2015; Okada et al., 2014) . However, it remains unclear whether these disease phenotypes are controlled by a common genetic mechanism, or if these phenotypes are mediated by distinct genes that are in LD within the chromosome 11 locus. In fact, this locus contains several genes comprising a haplotype that arose very recently in human evolution. The derived haplotype D has rapidly become the common allele in modern humans and is associated with more efficient synthesis of long-chain polyunsaturated fatty acids (LC-PUFAs) and increased hepatic expression of the rate-limiting enzymes in this process (FADS1 and FADS2) (Ameur et al., 2012) . It has been proposed that haplotype D imparted a selective advantage for early humans with limited dietary intake of LC-PUFA precursors (Ameur et al., 2012) , but in combination with a modern high-fat diet, it is associated with increased proinflammatory lipids (arachidonic acids), risk for CAD (Kwak et al., 2011; Lappalainen et al., 2013; Li et al., 2013; Martinelli et al., 2008; Tanaka et al., 2009) , and RA (Okada et al., 2014) . Whereas haplotype D is associated with a proinflammatory lipid profile and RA, it is not associated with IBD. In contrast, the IBD risk allele tagged by rs174537 is associated with the ancestral haplotype A and is characterized by lower levels of proinflammatory arachidonic acids (Hester et al., 2014; Jostins et al., 2012; Lappalainen et al., 2013; Liu et al., 2015; Tanaka et al., 2009) . Furthermore, evidence supporting a contribution of LC-PUFAs to IBD is lacking (Ananthakrishnan et al., 2014; Costea et al., 2014; Guan et al., 2014) . Collectively, these observations reveal the limitations of genetics in assigning causality of risk loci to specific genes and highlight the need for a combined functional-genetic approach to link genes with IBD risk. Here, we provide genetic evidence implicating TMEM258 in IBD risk and functionally identify the role for this gene in controlling ER stress responses in the colonic epithelium.
RESULTS

Expression of TMEM258 in Ileal Biopsies Exceeds All
Other Genes in the Chromosome 11: 61.5-61.65 Locus Given the gene-dense landscape of the chromosome 11 (61.5-61.65 Mb) locus and sparse functional annotation of the genes (Jostins et al., 2012; Lappalainen et al., 2013; Okada et al., 2014) for each phenotype mapped as chromosomal location versus significance (-Log10 P). (B) Expression of candidate genes determined by RNA-seq from ileum biopsies of IBD patients and controls (Haberman et al., 2014) . RPKM, reads per kilobase per million. Data represent mean and SD. (C) The expression of Tmem258 was overlaid on intestinal single-cell RNA-seq profiles (Gr€ un et al., 2016) . Enterocyte, goblet, and Paneth cell markers were used to construct a t-SNE plot.
therein, we sought to prioritize candidate causal genes that contribute to IBD pathophysiology. First, we compared the most significant SNPs in the chromosome 11 locus and their respective associations with three phenotypes: CD risk (Jostins et al., 2012) , RA risk (Okada et al., 2014) , and elevated arachidonic acid in blood samples (Lappalainen et al., 2013) . For all three phenotypes, an overlapping set of associated SNPs span coding regions for TMEM258, FADS1, and FADS2 ( Figure 1A ). By interrogating expression levels of candidate genes in ileum biopsies (Haberman et al., 2014) , we found that TMEM258 was expressed at dramatically higher levels than all other neighboring genes in its locus ( Figure 1B) . Moreover, examination of Tmem258 expression in a published dataset of single-cell transcriptomics (Gr€ un et al., 2016) revealed highest expression in secretory cell types such as goblet and Paneth cells with slightly lower expression in absorptive enterocytes ( Figure 1C ). Given these findings, we prioritized TMEM258 for deep functional characterization.
TMEM258 Controls the ER Stress Response
TMEM258 encodes a small 76-amino acid protein containing two predicted transmembrane domains and no additional functional domains that can be readily identified. Nevertheless, TMEM258 is highly conserved from mammals to flies and worms and ubiquitously expressed across human tissues (Figures S1A and S1B). To determine a biological role for TMEM258, we initially sought to define its function by knockout, so as to then evaluate the effects of IBD-associated variants on its function. Thus, we aimed to identify functional pathway-level perturbations after ablating TMEM258 expression. Toward this end, we knocked down TMEM258 in HeLa cells by means of lentiviral transduction with small hairpin RNAs (shRNAs) and performed transcriptomic analyses by RNA sequencing (RNA-seq). Strikingly, TMEM258 knockdown led to significant upregulation of genes related to glycoprotein modification, chaperone-mediated protein folding, proteostasis, and ER homeostasis ( Figures  2A, S1C , and S1D). In light of these findings, we hypothesized that TMEM258 regulates ER stress responses. To test this hypothesis, we compared genes upregulated by TMEM258 knockdown to previously defined ER stress signatures associated with the transcription factors ATF4, XBP1, and ATF6 ( Figure 2A ). Previously published datasets used in Figure 2A are available in GEO: GSE35681, GSE44951, GSE15759. An unbiased gene set enrichment analysis revealed statistically significant overlap between TMEM258 knockdown and the ER stress response induced by tunicamycin, which inhibits protein glycosylation ( Figure 2B ). In fact, genetic knockdown of TMEM258 induced hypersensitivity to tunicamycin, resulting in cell death (Figure 2C ). Our findings indicate that ER-localized TMEM258 (Figure 2D Figure S1 .
cell lineages, BV-2 macrophages and BW5147 T lymphocytes ( Figure S2 ; Table  S1 ). Strikingly, we detected nearly identical interaction partners for TMEM258 in both cell lines, despite their distinctly specialized lineages ( Figure 3A) . Moreover, we identified all known subunits of the OST complex as TMEM258 interactors ( Figures 3A and 3B ). In this context, the OST is strictly required for N-linked protein glycosylation, wherein it transfers a 14-sugar oligosaccharide from dolichol to asparagine residues on nascently translated proteins. Thus, N-linked glycosylation facilitates protein folding and maintains ER quality control. Consistent with this notion, we found that TMEM258 silencing dramatically reduced glycoprotein surface content, as determined by reactivity to concanavalin A, a lectin that specifically binds to a-Dmannosyl and a-D-glucosyl moieties ( Figure 3C ).
To further define the role for TMEM258 in N-linked glycosylation, we monitored maturation of the prototypical glycoprotein basigen (BSG). In control knockdown experiments, nascently translated BSG was N-glycosylated in the ER and trafficked to the Golgi apparatus for further glycosylation. These glycosylation events were reflected as an upshift in gel mobility, which was reversed by treatment with the endoglycosidase PNGaseF ( Figure 3D ). Strikingly, BSG gel mobility in TMEM258 knockdown samples was equivalent to PNGaseF-treated samples from control knockdown, indicating that TMEM258 is required for N-linked glycosylation ( Figure 3D ). Collectively, these findings demonstrate that TMEM258 depletion results in defective N-linked glycosylation, profound ER stress (Figure 2 ), and perturbed ER homeostasis. Thus, N-linked glycosylation is tightly regulated to maintain ER homeostasis, and TMEM258 expression levels are a significant factor in governing the efficiency of glycosylation.
Tmem258 Controls Intestinal Inflammation in Mice
To determine the role of TMEM258 in intestinal inflammation, we developed a knockout mouse model (Figures S3A and S3B) with the aim of eliciting ER stress by perturbing N-linked glycosylation. Whereas haploinsufficient Tmem258 +/À mice were viable and fertile, we did not obtain any homozygous Tmem258 À/À mice from multiple breeding pairs, nor did we detect any signs of fetal resorption in timed matings. Given that complete deficiency of Tmem258 is early embryonic lethal, we reasoned that it functions in a fundamental biological process that may be revealed in haploinsufficient Tmem258 Table S2 ).
Tmem258 Limits ER Stress and Prevents Apoptosis in Colonic Epithelial Cells
In the context of intestinal pathology, we hypothesized that TMEM258 plays a central role in secretory cell types that have a large translational load, such as Paneth cells and goblet cells, which secrete large quantities of antimicrobial peptides and mucins respectively. In unmanipulated mice, Tmem258 haploinsufficiency did not induce dramatic ER stress in the colonic epithelium, but after induction of colitis with DSS, we observed clear evidence of elevated ER stress in Tmem258 +/À mice relative to WT controls. Specifically, Tmem258 haploinsufficiency led to increased frequencies of epithelial cells that stained positive for BiP/GRP78 (HSPA5) ( Figures 5A and S6 ), a major transcriptional target of the unfolded protein response that functions as a chaperone and regulator of ER stress sensors such as IRE1, PERK, and ATF6. Moreover, we detected a greater frequency of apoptotic epithelial cells, as assessed by positive staining for active caspase 3, in Tmem258 +/À mice compared to controls. Consistent with the notion that TMEM258 performs a protective function in the context of ER-stress-mediated apoptosis, we observed massive crypt ablation and disorganized dispersion of Ki67-positive proliferating cells in Tmem258 +/À mice ( Figure 5A ).
To precisely define the impact of Tmem258 deficiency in colonic epithelial cells, we sought to generate homozygous null organoid cultures. We hypothesized that complete deficiency of Tmem258 would result in unresolved ER stress and rapid apoptosis. Thus, we devised a CRISPR-based approach to (A) Mice were administered 2.5% DSS in drinking water for 7 days. Mortality was monitored daily. *p < 0.05 Gehan-Breslow-Wilcoxon test (survival). n = 5-6 mice per genotype for two independent experiments. (B) At day 8, tissue sections were obtained and stained with hematoxylin and eosin. Arrows, inflammation; bracket, epithelial proliferation; dashed line, crypt damage. Scale bar, 25 mm. (C) Additionally, mice were assigned an overall health score (severity) and colon lengths were measured. Data represent mean and SD. *p < 0. Figures 5B and 5C ). Importantly, this observation was consistent across two independent Tmem258 sgRNAs and two independent control sgRNAs. Moreover, lentiviral titers were similar between all sgRNAs, suggesting that Tmem258 CRISPR induces cell death in organoids. Morphologically, Tmem258 CRISPR organoids contained scattered Cas9-GFP-positive cells within small spheroids that encapsulated numerous dead cells within the lumen ( Figure 5B ). In contrast, control CRISPR organoids appeared healthier and larger with contiguous Cas9-GFP-positive cells, suggestive of active proliferation ( Figures 5B and 5C ). Among Cas9-GFPpositive cells, insertion/deletion mutations were observed with both Tmem258 and control CRISPR, but more in-frame mutations were detected in Tmem258 CRISPR ( Figure 5D ). This observation suggests that out-of-frame alleles are negatively selected, consistent with our finding that Tmem258 deletion increases ER stress and cell death in colonic organoids ( Figures  5B and 5C ).
Increased Expression of TMEM258 Associates with IBD Risk and Impaired Secretion of Glycoproteins
To determine how genetic variation associated with IBD risk impacts TMEM258 function, we fine-mapped eQTL signals within the chromosome 11 (61.5-61.65) locus to determine the impact of the IBD risk allele for rs174537 on gene expression. Using the Geuvadis dataset (Tintle et al., 2015) , which is composed of matched genome sequences and transcriptomes from immortalized lymphoblasts, we found a strong eQTL effect for rs174538 on TMEM258, wherein the minor allele was associated with increased expression. Importantly, rs174538 is in LD with the IBD risk SNP rs174537 (r 2 0.86, D 0 0.98), and the minor alleles for both SNPs correspond to IBD risk and increased expression of TMEM258 ( Figure 6A ). Although we also observed eQTL effects for rs174538 on other genes in the locus, these residual effects regressed-out after adjusting for additional eQTLs in the locus. Thus, the dominant IBD risk SNP (rs174537) significantly increases expression of TMEM258, whereas the dominant RA SNP decreases expression of FADS1 (data not shown). Given these findings, we hypothesized that TMEM258 expression above or below optimal levels may alter the stoichiometry of the OST complex and impair its catalytic assembly or activity.
To identify the OST subunits with which TMEM258 interacts, we used V5-tagged TMEM258 as bait in co-immunoprecipitation experiments. Accordingly, we found that TMEM258 specifically interacts with RPN1, and co-expression of both proteins elevates their steady state levels ( Figure 6B ). Given that RPN1 was previously shown to interact with the lectin MLEC and inhibit secretion of glycoproteins (Qin et al., 2012) , we sought to determine the impact of elevated expression of TMEM258 on protein secretion. Toward this end, we transfected HEK293T cells with TMEM258 (or GFP control) and monitored secretion of the glycoprotein alpha 1 anti-trypsin. Strikingly, elevated expression of TMEM258 resulted in impaired glycosylation and secretion of this prototypical secretory protein ( Figure 6C ). Taken together with evidence from human IBD genetics, our results suggest that perturbation of TMEM258 expression profoundly impacts protein glycosylation and ER stress responses. Moreover, intestinal homeostasis is particularly susceptible to perturbation by pathological ER stress resulting from impaired protein glycosylation.
DISCUSSION
The chromosome 11 (61.5-61.65) locus contains five proteincoding genes and has been associated with three distinct phenotypes: IBD (Jostins et al., 2012) , RA (Okada et al., 2014) , and inflammatory lipid synthesis (Lappalainen et al., 2013) . Due to a relatively recent positive selection event acting on the locus, extensive LD spans the region. One feasible explanation for this positive selection is that a derived FADS genotype, associated with efficient lipid synthesis, provided a selective advantage to early humans (Ameur et al., 2012) . While overwhelming evidence supports the notion that lipid phenotypes are governed by genetic variants that impact FADS function, positive selection for FADS genotypes may have passively selected all genetic variants in LD with FADS, and more importantly, all phenotypes conferred by those variants. Indeed, the derived haplotype at this locus is more common than the ancestral haplotype and is associated with increased levels of serum phospholipids and arachidonic acid (Ameur et al., 2012; Hester et al., 2014) . While the impact of FADS1 and FADS2 enzymatic function on lipid metabolism likely contributes to risk for CAD and RA, it is not clear that this is the case for IBD. In fact, IBD risk is associated with the ancestral haplotype, whereas RA and CAD are associated with the derived haplotype. Moreover, we report that the IBD risk allele marked by rs174537 has a significant eQTL effect associated with increased expression of TMEM28. In contrast, the RA risk allele from this locus (rs968567) is associated with an eQTL effect resulting in decreased expression of FADS1. Collectively, our findings support the interpretation that IBD risk is conferred by TMEM258, while RA and lipid phenotypes are controlled by effects on FADS.
Given that no clear function has yet been attributed to TMEM258 in vivo, its association with IBD was not immediately evident. Here, we identify TMEM258 as a central regulator of intestinal homeostasis and demonstrate its requirement for efficient N-linked protein glycosylation and protection from ERstress-induced apoptosis. During the course of generating the Tmem258 knockout mouse and preparation of this manuscript, another report found that TMEM258 interacts with the OST complex and controls glycosylation (Blomen et al., 2015) . Our results extend these findings and map the interaction between TMEM258 and the essential OST subunit RPN1. Moreover, we have generated a mouse knockout model to link TMEM258 function with intestinal homeostasis. Further analysis of human genetic data indicates that the IBD risk haplotype in the chromosome 11 (61.5-61.65) locus is associated with increased expression of TMEM258. In this context, ectopic expression of TMEM258 impairs OST-mediated glycosylation and secretion. As a subunit of the large multi-subunit OST complex, TMEM258 abundance above or below optimal levels may alter the stoichiometry of the complex and impair its catalytic assembly or activity. Consequently, our data implicate perturbation in protein glycosylation in the induction of pathological ER stress and intestinal inflammation.
The ER stress response is mediated by three interconnected networks of sensors and effectors. Accumulation of unfolded proteins in the ER is sensed by the chaperone Bip/Grp78 (HSPA5), which then dissociates from and activates ATF6 (ATF6), IRE1 (ERN1 and 2), and PERK (EIF2AK3). In turn, ATF6 elicits transcriptional activation of the cytoprotective unfolded protein response. Similarly, IRE1 controls transcription of a subset of unfolded protein response genes by initiating splicing and activation of the transcription factor XPB1. In contrast, PERK activation triggers cell death in response to unresolved ER stress by activating ATF4 and the executioner CHOP (DDIT3). In the context of pathological ER stress, GWASs and fine mapping studies have associated IBD with several genes involved in the ER stress response, such as ATF4 and ERN2 (IRE1-b) (Jostins et al., 2012) . Moreover, hypomorphic variants of XBP1 are susceptibility factors in Crohn's disease and ulcerative colitis (Kaser et al., 2008) . In mouse models, conditional deletion of Xbp1 or Ire1a (Ern1) leads to colitis resulting from excessive ER stress and apoptosis induced by CHOP (DDIT3) (Kaser et al., 2008; Zhang et al., 2015) . Thus, mounting evidence highlights genes and pathways involved in ER homeostasis as critical genetic factors imparting risk to IBD.
From a broader perspective, the ER stress response has been proposed to engage in pathway-level interactions with additional processes underlying IBD pathophysiology. Specifically, a Crohn's disease risk variant of the autophagy gene ATG16L1 is associated with elevated ER stress in Paneth cells and poor prognosis in patients (Deuring et al., 2014) . Moreover, ER stress in goblet cells can be ameliorated by stimulation of IL10, another IBD-associated gene . With mounting evidence implicating the ER stress response in several immunological diseases including arthritis and interstitial lung disease (Bettigole and Glimcher, 2015; Watkin et al., 2015) , approaches aimed at alleviating pathological ER stress may represent a therapeutic opportunity in a range of pathological contexts Fu et al., 2015) .
EXPERIMENTAL PROCEDURES DSS-Induced Acute Colitis
Mice were given 2.5% (w/v) dextran sulfate sodium (DSS, MP Biomedicals; MW = 36,000-50,000) dissolved in drinking water for 7 days, after which regular drinking water was substituted. With the exception of the survival analysis, mice were euthanized at day 8, and colons were assessed for length and histology. Clinical assessment of DSS-treated mice included daily evaluation of weight loss, stool consistency, blood in stool, posture, ruffled fur, and mobility. Each parameter was individually scored (ranging from 0-3) and disease severity (0-15) was calculated by sum of individual scores.
Histology
The colon was extracted from DSS-treated mice and divided into proximal, middle, and distal sections, and fixed in 10% formalin. Sections were stained with H&E, and histologic examination was performed in a blinded fashion using a modified validated scoring system (Krieglstein et al., 2007) . Three independent parameters were measured: (1) severity of inflammation, (2) depth of injury/inflammation, and (3) crypt damage. Each score was multiplied by a factor reflecting a percentage of the tissue involved, generating a maximum possible score of 40. The histopathology score was the sum of the scores obtained from the three segments of the colon, yielding a maximum possible score of 120 (Kabashima et al., 2002) . To detect epithelial cell proliferation, tissues sections were immunostained for Ki-67 and the frequency of Ki-67-positive epithelial cells was quantitated.
RNA-Seq on Colon Samples
Mice were administered DSS as described above, and RNA was purified from colon tissue samples by Trizol extraction (Life Technologies). Purified RNA was treated with Turbo DNase (Thermo Fisher Scientific) prior to first-strand cDNA synthesis and template switching with Maxima reverse transcriptase (Thermo Fisher Scientific). PolydT oligos were appended on the 5 0 end with sample barcodes, unique molecular identifier sequences, and a truncated Illumina adaptor. Template switch oligos were composed of a truncated Illumina adaptor and three modified ribocytosines at the 3 0 end. Following reverse transcription, samples were treated with RNaseH (Thermo Fisher Scientific) and subjected to second-strand cDNA synthesis with NEBnext (NEB). Doublestranded cDNA (1 ng) was then tagmented with the Nextera XT kit (Illumina) for 15 min, followed by 12-cycle PCR to generate 3 0 DGE libraries. Samples were pooled to a final concentration of 4 nM and sequenced with a 50-cycle MiSeq kit (Illumina) by paired-end reads of 21 and 40 cycles followed by one adaptor read.
shRNA Knockdown HeLa cells (ATCC) were seeded in 24-well plates at 3.4 3 10 4 /300 mL media.
After 24 hr, cells were transduced with 150 mL lentiviral supernatant packaged in HEK293T cells. The following constructs were used to produce lentiviral particles: TMEM258-TRCN0000188656, TMEM258-TRCN0000160130, Luc-TRCN0000072264, and LacZ-TRCN0000072228 (from the Genetic Perturbation Platform, Broad Institute). Three days after transduction, cells were passaged into 6-well plates, and media was supplemented with puromycin (InvivoGen) at a concentration of 3 mg/ml. After 2 days in selection, cells were harvested for analysis.
Immunofluorescence
HeLa cells (ATCC) were transduced with lentivirus for ectopic expression of TMEM258 appended with an N-terminal V5 tag. Cells were seeded onto coverslips and allowed to adhere for 30 min at 37 C. Subsequently, cells were fixed in 4% paraformaldehyde for 15 min at 37 C and stained with mouse monoclonal anti-V5 (Invitrogen) and rabbit anti-Calnexin (Cell Signaling Technology) diluted 1:250 in staining buffer (3% BSA, 0.1% saponin, PBS). The following secondary antibodies were used at a 1:1,000 dilution in staining buffer: Alexa Fluor 488 goat anti-mouse immunoglobulin G (IgG) (Life Technologies R37121) and Alexa Fluor594 goat anti-rabbit IgG (Life Technologies A27034). Cells were mounted in Vectashield medium containing DAPI (Vector Laboratories) and imaged with a Zeiss Axio A1 microscope equipped with 633/1.25 objective. Image acquisition was performed with the AxioVision (Rel.4.8) software package.
RNA-Seq on HeLa Cells
TMEM258 was knocked down in HeLa cells as described above. Cells were lysed, and mRNA was purified with polydT microbeads (Dynabeads mRNA Direct Kit, Invitrogen). First-strand cDNA synthesis with template switching was performed as described above. Second-strand cDNA was generated by NEBnext kit (NEB). Double-stranded cDNA (0.5 ng) was then tagmented with the Nextera XT kit (Illumina) for 12 min, followed by a 12-cycle PCR to amplify the whole transcriptome. Samples were then pooled to a final concentration of 4 nM and sequenced with a 50-cycle MiSeq kit (Illumina) by paired-end reads of 30 and 29 cycles followed by two adaptor reads.
Tunicamycin Stress Test
TMEM258 was knocked down in HeLa cells as described above. Cells were treated with escalating doses of tunicamycin (Sigma Aldrich) for 4 days. Cell viability was then monitored by Alamar blue reagent (Invitrogen) according to the manufacturer's recommendations.
Glycosylation Assays
TMEM258 knockdown was performed in HeLa cells as described above. Cells were then gently scraped off the plate and washed in serum-free DMEM prior to lectin staining with 1 mg FITC-concanavalin A (Sigma). All samples were run on an Accuri C6 flow cytometer (Becton Dickinson) and analyzed with FlowJo software. In addition, HeLa cells grown to confluency in 6-well plates were subjected to western blot for the glycoprotein reporter basigen (BSG). Designated samples were deglycosylated with PNGaseF according to the manufacturer's protocol (NEB). Samples were then resolved by PAGE, and western blot was performed to detect Bsg (anti-CD147, clone EPR4052, Abcam).
Immunoprecipitation
HEK293T cells (ATCC) were transfected with Lipofectamine 2000 (Invitrogen)
as recommended by the manufacturer. The indicated cDNA constructs were cloned as PCR products into pCMV (Invitrogen) by Gibson assembly. Transfected cells were lysed (1% Triton X-100, PBS [pH 7.4]), and V5-TMEM258 was immunoprecipitated with anti-V5 magnetic agarose beads (MBL International) with rotation at 4 C for 4 hr. Samples were then resolved by PAGE, and western blot was performed with horseradish peroxidase (HRP)-conjugated anti-FLAG (anti-DYKDDDDK, Cell Signaling Technologies) to detect RPN1-FLAG. In secretion studies, HEK293T cells were transfected with the indicated cDNA constructs as described above. Secreted alpha 1 anti-trypsin (SerpinA1-V5) was immunoprecipitated from culture supernatant as described above. Samples were then resolved by PAGE, and western blot was performed with HRP-conjugated anti-V5 (Sigma Aldrich).
Immunofluorescence on Colon Samples
Colon samples were fixed in 10% formalin, embedded in paraffin, and sectioned. Rehydration was performed by serial wash steps with Xylene 
Organoids
Procedures for establishing and maintaining mouse organoids/spheroids were based on a previously published method (Miyoshi and Stappenbeck, 2013 ). The only difference was the addition of Primocin antibiotic (InvivoGen 1:500) to all organoid media. In brief, crypts were isolated from mouse distal colon and suspended in Matrigel (BD Biosciences; 15 ml/well). Matrigel mixture was plated into 48-well tissue culture plates at room temperature. To prevent crypts from attaching to the plastic, plates were flipped and incubated at 37 C to polymerize the Matrigel. 500 mL of 50% L-WRN CM (Miyoshi et al., 2012) and fresh primary culture media (Advanced DMEM/F-12 [Invitrogen] supplemented with 20% fetal bovine serum, 2 mM glutaMAX, 100 units/mL penicillin, and 0.1 mg/mL streptomycin), supplemented with 10 mM Y-27632 (ROCK inhibitor; Tocris Bioscience, R&D Systems) and 10 mM SB 431542 (TGFBR1 inhibitor; Cayman Chemical Company) was added to each well. Organoids were passaged (1:3) every 1-3 days for 2 weeks up to transduction and every 2-3 days (1:2-1:3) following transduction. We followed the following steps to obtain single-cell suspensions of organoid cells for flow cytometry, fluorescence-activated cell sorting (FACS), and lentivirus transduction: culture media was removed from organoid/Matrigel well and 500 mL PBS EDTA (0.5 mM EDTA in PBS) was added to each well. We scratched and suspended the Matrigel with a 1000 mL pipette. Organoids were spun at 200 3 g for 5 min and PBS was removed to the level of the Matrigel containing organoids. Organoids were dissociated by incubation in 0.25% (w/v trypsin for 1 min followed by vigorous pipetting. Trypsin was washed with wash media and cells were then either transduced or stained for flow cytometry. Single-cell suspensions of organoids were obtained from two wells of Matrigel organoids and plated as one well in infection media (50% L-WRN media in DMEM/F12 + 10 mM Y-27632 + 10 mM SB 431542). 3 mL of each virus (concentrated by ultracentrifugation) was added per well (with four wells/virus/mouse) for a total volume of 250 ml/well. Cells were left to be transduced for 6 hr at 37 C. Organoid suspensions were then washed and replated in Matrigel (two wells/well transduced). For FACS sorting, single-cell suspensions were obtained and filtered (40 mm). DAPI was added just before the sort as a live/dead marker. Cells were sorted on GFP-positive DAPI-negative into TRIzol (Ambion).
For imaging, organoids were plated on chamber wells (Nunc Lab-Tek II Chamber slide system) with 50% L-WRN for 1 day and differentiation media (primary culture media and 5 mM N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-Sphenylglycine t-butyl ester [DAPT]) for 2 days. Organoids were then fixed in paraformaldehyde (PFA) for 1 hr at 37 C. All steps that followed were at room temperature. The tissue was permeabilized for 30 min in 1% Triton X-100 in PBS and then blocked for 1 hr at room temperature (2% BSA, 3% goat serum, 0.2% Triton in PBS). Primary antibodies (rabbit anti-GFP AlexaFluor647 [1:400], Life Technologies) were added to stain overnight in working buffer (0.2% BSA 0.2% Triton, 0.3% goat serum). Fixed organoids were washed all day in working buffer and stained overnight in secondary antibodies plus Hoechst. Organoids were washed four times, and the chamber was removed. Coverslips were mounted with ProLong Gold Antifade Reagent (Life Technologies). Organoids were imaged by confocal microscopy using a 403 objective.
CRISPR Design
All sgRNAs were designed for efficacy using sgRNA Designer (Doench et al., 2014) and for specificity with CCTop (Stemmer et al., 2015) . sgRNA sequences were as follows: exon 2 GAAGTACCACAGTCAGGTGA, exon 3 GTAGAGGTG ACCTCGTAACT, intronic 1 AGGAGGCTGGTGCTGCCCAA, intronic 2 GGTG GTTCATTGGTATTTGG. Guides were cloned as oligonucleotides into lenti-CRISPR v2 plasmid (Sanjana et al., 2014) in which spCas9-2A-PAC was replaced with cDNA encoding Cre recombinase. Genomic sequencing primers were as follows: forward i5adapter-TTCCTTAGGAGCTCGAAGCC and reverse i7adapter-GTCTCAATCCCACCTCAAAGGA, forward i5adapter-CCCCATGAAAGGTAGTCAGAGAC and reverse i7adapter-CCTGTTGATATG GCTCTACGAGG, forward i5adapter-TTTCCTTTGAGGTGGGATTGAGA and reverse i7adapter-CAGCTGGGACATGAGCACTT, forward i5adapter-TCCAA CTTCAAATTTGCTCAGTTTA and reverse i7adapter-TCGCCTCTAGCCTCTA GTCA. Sequencing was performed with a 150-cycle MiSeq kit (Illumina). (Platt et al., 2014) obtained from Jackson Laboratory.
Statistics
Statistical procedures specific for each technology are described in their respective sections above. For comparisons between two groups, unpaired Student's t tests (two-tailed) or non-parametric tests were employed. See figure legends for additional details.
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